Essential role of Ca2+/calmodulin in Early Endosome Antigen-1 localization.
Deirdre C Lawe, Nachida Sitouah, Susan Hayes, Anil Chawla, Joseph V Virbasius, Richard Tuft, Kevin Fogarty, Lawrence Lifshitz, David Lambright, Silvia Corvera
文献索引:Mol. Biol. Cell 14(7) , 2935-45, (2003)
全文:HTML全文
摘要
Ca2+ is an essential requirement in membrane fusion, acting through binding proteins such as calmodulin (CaM). Ca2+/CaM is required for early endosome fusion in vitro, however, the molecular basis for this requirement is unknown. An additional requirement for endosome fusion is the protein Early Endosome Antigen 1 (EEA1), and its recruitment to the endosome depends on phosphatidylinositol 3-phosphate [PI(3)P] and the Rab5 GTPase. Herein, we demonstrate that inhibition of Ca2+/CaM, by using either chemical inhibitors or specific antibodies directed to CaM, results in a profound inhibition of EEA1 binding to endosomal membranes both in live cells and in vitro. The concentration of Ca2+/CaM inhibitors required for a full dissociation of EEA1 from endosomal membranes had no effect on the activity of phosphatidylinositol 3-kinases or on endogenous levels of PI(3)P. However, the interaction of EEA1 with liposomes containing PI(3)P was decreased by Ca2+/CaM inhibitors. Thus, Ca2+/CaM seems to be required for the stable interaction of EEA1 with endosomal PI(3)P, perhaps by directly or indirectly stabilizing the quaternary organization of the C-terminal FYVE domain of EEA1. This requirement is likely to underlie at least in part the essential role of Ca2+/CaM in endosome fusion.
相关化合物
相关文献:
2015-08-01
[Neuropharmacology 95 , 395-404, (2015)]
1995-02-06
[Biochem. Biophys. Res. Commun. 207(1) , 452-9, (1995)]
1995-02-01
[J. Pharm. Pharmacol. 47(2) , 152-6, (1995)]
1996-02-01
[Cell Calcium 19(2) , 105-11, (1996)]
1998-05-01
[Prostaglandins Other Lipid Mediat. 56(1) , 1-6, (1998)]